Cargando…
Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!
Biomarkers or biosignature profiles have become accessible over time in population-based studies for Chagas disease. Thus, the identification of consistent and reliable indicators of the diagnosis and prognosis of patients with heart failure might facilitate the prioritization of therapeutic managem...
Autores principales: | Pinho, Rosa T., Waghabi, Mariana C., Cardillo, Fabíola, Mengel, José, Antas, Paulo R. Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980390/ https://www.ncbi.nlm.nih.gov/pubmed/27563302 http://dx.doi.org/10.3389/fimmu.2016.00306 |
Ejemplares similares
-
Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment
por: Mengel, Jose, et al.
Publicado: (2016) -
Editorial: The Role of Biomarkers in the Immunopathology and Diagnosis of Immune Exacerbations in Leprosy—New Frontiers to Manage This Neglected Disease
por: Antas, Paulo R. Z., et al.
Publicado: (2022) -
The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022) -
Scrutinizing the epigenetics revolution
por: Meloni, Maurizio, et al.
Publicado: (2014) -
Central nervous system commitment in Chagas disease
por: Useche, Yerly, et al.
Publicado: (2022)